Connect with us


CBD Treatment Case Diabetes



In surveying the various applications for CBD in terms of its impact in preventing and treating a wide variety of health conditions experienced by people all around the world, we have covered a lot of ground and noticed some interesting tendencies and trends.

Today, were going to take a close look at how diabetes plays into this narrative, and we will find below that it both confirms and challenges some of these ideas.

Understanding Diabetes

Diabetes falls into a group of disorders known as metabolic disorders. The issue here has to do with the instantiation of sustained high blood sugar levels and the deleterious effects that that can have for a number of different facets of human physiology.

At present, diabetes is one of the most widespread and prevalent health conditions experienced by people in the world today. Remarkably, recent statistics suggest that as much as 10% of the population of the United States is affected.

This rate is especially high when compared to the rest of the world. But even so, it is thought that over 370 million people are affected by diabetes around the world. Furthermore, and possibly more remarkably, it would appear that six out of every 10 of these people actually don’t realize that they suffer from diabetes in the first place.

In fact, diabetes is a specific dysfunction of a hormone (insulin). The role of this hormone is to provide for the transportation of glucose in the bloodstream throughout the body and into the cells.

Glucose is the principle form that energy takes in the body. It’s something like the body’s version of oil. Think of insulin as like a system of oil pipelines and tankers. You can imagine what would happen if a number of oil tankers were unable to make it to port.

You would soon see the lights turned off all around the town. This is something like what happens inside the body when insulin levels drop.

It is also important to understand that there are two very different types of diabetes.

Type I diabetes is a condition generally defined by a misappropriated attack from the immune system upon specific areas of the pancreas. The result is a lowering of the total production of insulin – which itself is produced in the pancreas. When this happens, various forms of sugars circulating through the body in the bloodstream are not able to transport themselves into the cells to be used as energy.

Type II diabetes, by contrast, results from an excess of fatty tissue actually blocking the transportation of insulin from the bloodstream and into the cell. This causes glucose to build up in the bloodstream. When this happens, the pancreas is signaled to produce extra insulin to remove the sugar.

However because this transportation mechanism is still dysfunctional, the final result of this exercise is eventual damage to the pancreas itself. Fortunately, there is a cure to type II diabetes: weight loss and exercise.

CBD and Diabetes

There are a number of different ways in which CBD can positively impact the life experience of a diabetic individual. We will look at a few here.

The first and most important insight is that CBD functions to regulate insulin levels in the body. As we have discussed, the endocannabinoid system is integral to many of the regulatory functions of the body. Insulin regulation is another example of this trend.

According to the American Journal of Medicine, studies have shown that CBD can lower insulin levels and balance the system dependent upon insulin in a manner that is unmatched among therapeutic options, according to data.

In addition, more research is suggesting that CBD actually can regulate the appetite.

Finally, it has been found the diabetes can lead to a condition known as retinopathy – damage to the retina and the leading cause of blindness for those with diabetes. The ultimate cause is actually abnormal blood flow, but this is driven by the various facets of the diabetes condition. Crucially, CBD has been shown to block the process that causes the degradation of blood vessels surrounding the eye and leading to diabetic retinopathy.

More research is needed, but this appears to be a potential breakthrough result with possibly massive implications.

Continue Reading


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories